Current Development Status of MEK Inhibitors

The current development status of mitogen-activated protein kinase kinase (MEK) inhibitors, including the preclinical data and clinical study progress, has been summarized in this review. Different MEK inhibitors, possessing specific physicochemical properties and bioactivity characteristics, may pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ying, Tian, Hongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151813/
https://www.ncbi.nlm.nih.gov/pubmed/28954413
http://dx.doi.org/10.3390/molecules22101551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151813/
https://www.ncbi.nlm.nih.gov/pubmed/28954413
http://dx.doi.org/10.3390/molecules22101551

Ejemplares similares